Cutaneous collagenous vasculopathy: development after coronary artery bypass surgery

Rahnama‐Moghadam, Sahand; Burgin, Callie; Gilbert, Juliana; Warren, Simon

doi:10.5070/d3245040142

Cited by 5 publications

(3 citation statements)

References 0 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…[13][14][15] A case of CCV developing after coronary artery bypass grafting was reported. 16 Association of CCV with benign pigmented purpura of Schamberg type was described in one case. 17 Association of CCV with multiple myeloma or Gaucher disease has not been reported to date.…”

Section: Discussionmentioning

confidence: 95%

“…Association of CCV with internal diseases (arterial hypertension, cardiovascular disease, dyslipidemia, diabetes mellitus, metabolic syndrome, and arrhythmia) and with certain medications (losartan, gemcitabine, and axitinib) has been described 13‐15 . A case of CCV developing after coronary artery bypass grafting was reported 16 . Association of CCV with benign pigmented purpura of Schamberg type was described in one case 17 .…”

Section: Discussionmentioning

confidence: 99%

See 1 more Smart Citation

A case of cutaneous collagenous vasculopathy associated with multiple myeloma and with a pathogenic variant of the glucocerebrosidase gene

et al. 2022

View full text Add to dashboard Cite

Cutaneous collagenous vasculopathy (CCV) is an extremely rare acquired microangiopathy of unknown etiology. The authors describe a case of a 68‐year‐old man, a carrier of a heterozygous pathogenic variant of the glucocerebrosidase (GBA) gene, who was diagnosed with CCV, revealing uncommon fibrinogen positivity in direct immunofluorescence. The patient was subsequently diagnosed with multiple myeloma. Treatment of the myeloma with combined chemotherapy including bortezomib, followed by autologous stem cell transplantation, led to significant reduction of cutaneous lesions. To the best of the authors' knowledge, this is the first published case of CCV in a carrier of a pathogenic variant of the GBA gene, associated with multiple myeloma and with significant regression of CCV after myeloma treatment. Direct immunofluorescence examination revealed an unusual fibrinogen deposition. Hypothetical causative role of bortezomib treatment was proposed regarding significant regression of CCV.

show abstract

Section: Discussionmentioning

confidence: 95%

Section: Discussionmentioning

confidence: 99%

A case of cutaneous collagenous vasculopathy associated with multiple myeloma and with a pathogenic variant of the glucocerebrosidase gene

et al. 2022

View full text Add to dashboard Cite

show abstract

“…CCV has been associated with common comorbidities, such as hypertension and diabetes, 10 and drugs, including antineoplastic agents 11 . It has also been shown to arise soon after coronary artery bypass grafting, 12 and theorized to be associated with a genetic defect in collagen synthesis 13 . CCV does not require treatment, though two reports have demonstrated successful treatment with pulsed dye laser 14,15 …”

Section: Figurementioning

confidence: 99%